| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Memory | 41 | 2020 | 191 | 11.850 |
Why?
|
| Drosophila melanogaster | 34 | 2021 | 43 | 8.880 |
Why?
|
| Drosophila Proteins | 37 | 2021 | 45 | 8.860 |
Why?
|
| Mushroom Bodies | 34 | 2021 | 34 | 8.250 |
Why?
|
| Smell | 31 | 2018 | 48 | 7.310 |
Why?
|
| Neurons | 33 | 2020 | 416 | 6.990 |
Why?
|
| Drosophila | 32 | 2019 | 35 | 6.400 |
Why?
|
| Learning | 12 | 2019 | 80 | 3.440 |
Why?
|
| Conditioning, Classical | 18 | 2019 | 26 | 3.110 |
Why?
|
| Animals | 82 | 2021 | 7570 | 3.060 |
Why?
|
| Olfactory Pathways | 13 | 2018 | 16 | 3.010 |
Why?
|
| Avoidance Learning | 8 | 2019 | 19 | 2.970 |
Why?
|
| Synapses | 12 | 2020 | 83 | 2.880 |
Why?
|
| Memory Disorders | 10 | 2017 | 54 | 2.480 |
Why?
|
| Animals, Genetically Modified | 25 | 2018 | 67 | 2.020 |
Why?
|
| Olfactory Perception | 5 | 2018 | 10 | 1.920 |
Why?
|
| Brain | 15 | 2018 | 946 | 1.750 |
Why?
|
| MicroRNAs | 4 | 2016 | 188 | 1.650 |
Why?
|
| Aging | 6 | 2018 | 938 | 1.500 |
Why?
|
| Behavior, Animal | 16 | 2018 | 253 | 1.370 |
Why?
|
| Dopamine | 7 | 2021 | 234 | 1.220 |
Why?
|
| High-Throughput Screening Assays | 2 | 2020 | 13 | 1.210 |
Why?
|
| Transcription Factors | 12 | 2016 | 176 | 1.180 |
Why?
|
| Synaptic Transmission | 7 | 2016 | 115 | 1.170 |
Why?
|
| Olfactory Receptor Neurons | 6 | 2016 | 7 | 1.080 |
Why?
|
| Nerve Tissue Proteins | 3 | 2018 | 117 | 1.050 |
Why?
|
| Cyclic AMP | 6 | 2018 | 45 | 1.040 |
Why?
|
| Central Nervous System | 3 | 2021 | 43 | 1.010 |
Why?
|
| Neuronal Plasticity | 7 | 2015 | 80 | 0.930 |
Why?
|
| Receptors, Dopamine D1 | 3 | 2021 | 18 | 0.810 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 76 | 0.800 |
Why?
|
| Mitochondria | 3 | 2020 | 206 | 0.780 |
Why?
|
| Calcium | 9 | 2016 | 323 | 0.740 |
Why?
|
| Hippocampus | 4 | 2012 | 171 | 0.730 |
Why?
|
| Nerve Net | 4 | 2017 | 125 | 0.720 |
Why?
|
| Synaptic Vesicles | 2 | 2018 | 7 | 0.710 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 316 | 0.710 |
Why?
|
| Models, Animal | 3 | 2018 | 171 | 0.700 |
Why?
|
| Association Learning | 4 | 2009 | 14 | 0.680 |
Why?
|
| Gene Expression Regulation | 9 | 2016 | 475 | 0.680 |
Why?
|
| Mental Recall | 1 | 2021 | 51 | 0.670 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 71 | 0.640 |
Why?
|
| ras Proteins | 1 | 2020 | 10 | 0.640 |
Why?
|
| Memory, Short-Term | 2 | 2018 | 60 | 0.640 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2017 | 192 | 0.630 |
Why?
|
| Signal Transduction | 6 | 2016 | 687 | 0.590 |
Why?
|
| Histone Acetyltransferases | 2 | 2018 | 6 | 0.570 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 64 | 0.570 |
Why?
|
| Receptors, GABA-A | 2 | 2009 | 32 | 0.570 |
Why?
|
| Electroshock | 6 | 2019 | 20 | 0.560 |
Why?
|
| Time Factors | 11 | 2021 | 2183 | 0.560 |
Why?
|
| Receptors, Dopamine | 1 | 2017 | 19 | 0.540 |
Why?
|
| Neuropeptides | 5 | 2012 | 19 | 0.540 |
Why?
|
| Neurogenesis | 1 | 2017 | 16 | 0.540 |
Why?
|
| Granulocytes | 1 | 2017 | 11 | 0.530 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2012 | 154 | 0.530 |
Why?
|
| BCG Vaccine | 1 | 2017 | 7 | 0.530 |
Why?
|
| Feedback | 1 | 2017 | 42 | 0.520 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2016 | 9 | 0.520 |
Why?
|
| Axons | 3 | 2019 | 33 | 0.510 |
Why?
|
| Putamen | 1 | 2016 | 25 | 0.510 |
Why?
|
| Caudate Nucleus | 1 | 2016 | 25 | 0.510 |
Why?
|
| Mutation | 6 | 2011 | 493 | 0.500 |
Why?
|
| Cation Transport Proteins | 1 | 2016 | 24 | 0.500 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2016 | 1 | 0.490 |
Why?
|
| Cholinergic Fibers | 1 | 2016 | 7 | 0.490 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 69 | 0.470 |
Why?
|
| Data Interpretation, Statistical | 3 | 2012 | 114 | 0.460 |
Why?
|
| Female | 18 | 2021 | 20271 | 0.460 |
Why?
|
| rac GTP-Binding Proteins | 2 | 2016 | 2 | 0.450 |
Why?
|
| Base Sequence | 3 | 2016 | 247 | 0.440 |
Why?
|
| Trans-Activators | 3 | 2004 | 42 | 0.440 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 38 | 0.440 |
Why?
|
| Membrane Proteins | 1 | 2016 | 251 | 0.440 |
Why?
|
| Sleep | 1 | 2015 | 89 | 0.440 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2010 | 75 | 0.430 |
Why?
|
| Burns | 2 | 2012 | 100 | 0.430 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2016 | 10 | 0.420 |
Why?
|
| Armadillo Domain Proteins | 1 | 2013 | 1 | 0.410 |
Why?
|
| Polyamines | 1 | 2013 | 11 | 0.410 |
Why?
|
| Neuroprotective Agents | 1 | 2013 | 27 | 0.410 |
Why?
|
| Autophagy | 1 | 2013 | 55 | 0.400 |
Why?
|
| Electric Stimulation | 4 | 2021 | 106 | 0.380 |
Why?
|
| Appetite Regulation | 1 | 2012 | 2 | 0.380 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2016 | 67 | 0.380 |
Why?
|
| Cells, Cultured | 5 | 2020 | 820 | 0.370 |
Why?
|
| Models, Statistical | 2 | 2012 | 180 | 0.370 |
Why?
|
| Mice | 9 | 2018 | 2512 | 0.360 |
Why?
|
| Carrier Proteins | 2 | 2016 | 136 | 0.360 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 60 | 0.350 |
Why?
|
| Dynamins | 2 | 2012 | 2 | 0.350 |
Why?
|
| Saccharomyces cerevisiae Proteins | 6 | 2008 | 17 | 0.340 |
Why?
|
| Green Fluorescent Proteins | 5 | 2012 | 72 | 0.340 |
Why?
|
| Bone Density | 2 | 2010 | 203 | 0.340 |
Why?
|
| Space Perception | 2 | 2008 | 28 | 0.340 |
Why?
|
| Casein Kinase I | 1 | 2010 | 1 | 0.330 |
Why?
|
| Gene Knockdown Techniques | 3 | 2018 | 77 | 0.330 |
Why?
|
| Transgenes | 6 | 2013 | 49 | 0.330 |
Why?
|
| Neurofibromatosis 1 | 1 | 2010 | 9 | 0.330 |
Why?
|
| Conditioning, Operant | 2 | 2011 | 86 | 0.330 |
Why?
|
| Phenotype | 7 | 2020 | 638 | 0.330 |
Why?
|
| Dendrites | 3 | 2021 | 16 | 0.320 |
Why?
|
| Vibration | 1 | 2010 | 10 | 0.320 |
Why?
|
| Long-Term Potentiation | 2 | 2007 | 15 | 0.320 |
Why?
|
| Spinal Cord Injuries | 1 | 2010 | 40 | 0.310 |
Why?
|
| Osteoporosis | 1 | 2010 | 71 | 0.300 |
Why?
|
| Male | 16 | 2018 | 19650 | 0.290 |
Why?
|
| Gene Expression | 2 | 2015 | 334 | 0.290 |
Why?
|
| Humans | 19 | 2018 | 32814 | 0.290 |
Why?
|
| Orientation | 1 | 2008 | 24 | 0.280 |
Why?
|
| Circadian Rhythm | 1 | 2008 | 45 | 0.280 |
Why?
|
| Integrin alpha3 | 1 | 2007 | 1 | 0.270 |
Why?
|
| Action Potentials | 2 | 2005 | 186 | 0.260 |
Why?
|
| RNA, Messenger | 3 | 2005 | 498 | 0.260 |
Why?
|
| Pheromones | 1 | 2007 | 3 | 0.260 |
Why?
|
| Sexual Behavior, Animal | 1 | 2007 | 8 | 0.260 |
Why?
|
| Drug Tolerance | 1 | 2007 | 32 | 0.260 |
Why?
|
| Gender Identity | 1 | 2007 | 28 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 2 | 2004 | 208 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 789 | 0.250 |
Why?
|
| Central Nervous System Depressants | 1 | 2007 | 63 | 0.250 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 26 | 0.250 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 15 | 0.240 |
Why?
|
| RNA Probes | 1 | 2005 | 4 | 0.240 |
Why?
|
| Motor Activity | 2 | 2005 | 327 | 0.230 |
Why?
|
| Neural Pathways | 1 | 2005 | 95 | 0.230 |
Why?
|
| Vision, Ocular | 1 | 2005 | 32 | 0.230 |
Why?
|
| Neutrophils | 2 | 2017 | 110 | 0.220 |
Why?
|
| Neurosciences | 1 | 2005 | 11 | 0.220 |
Why?
|
| Ethanol | 1 | 2007 | 191 | 0.220 |
Why?
|
| DNA-Binding Proteins | 5 | 2008 | 142 | 0.220 |
Why?
|
| Mice, Knockout | 6 | 2012 | 453 | 0.210 |
Why?
|
| Gene Targeting | 1 | 2004 | 16 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2008 | 18 | 0.210 |
Why?
|
| Analysis of Variance | 4 | 2012 | 459 | 0.210 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2003 | 15 | 0.200 |
Why?
|
| Integrins | 1 | 2003 | 15 | 0.200 |
Why?
|
| Research Design | 1 | 2005 | 332 | 0.200 |
Why?
|
| Image Enhancement | 1 | 2003 | 70 | 0.200 |
Why?
|
| Pattern Recognition, Automated | 1 | 2003 | 36 | 0.200 |
Why?
|
| Appetitive Behavior | 2 | 2014 | 6 | 0.200 |
Why?
|
| Repressor Proteins | 3 | 2012 | 50 | 0.190 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 282 | 0.190 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2003 | 134 | 0.190 |
Why?
|
| Cell Nucleus | 1 | 2003 | 105 | 0.190 |
Why?
|
| Eye | 1 | 2002 | 16 | 0.190 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2003 | 112 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 225 | 0.190 |
Why?
|
| Age Factors | 3 | 2018 | 1197 | 0.190 |
Why?
|
| Models, Biological | 3 | 2012 | 392 | 0.180 |
Why?
|
| Molecular Sequence Data | 2 | 2016 | 352 | 0.170 |
Why?
|
| Genes, Insect | 3 | 2005 | 4 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2020 | 1 | 0.160 |
Why?
|
| Propiophenones | 1 | 2020 | 4 | 0.160 |
Why?
|
| Algorithms | 1 | 2003 | 511 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 9 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 13 | 0.160 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 55 | 0.160 |
Why?
|
| Ion Channels | 2 | 2012 | 24 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 26 | 0.150 |
Why?
|
| Cellulose, Oxidized | 1 | 2018 | 3 | 0.150 |
Why?
|
| Sucrose | 2 | 2012 | 18 | 0.150 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2018 | 6 | 0.150 |
Why?
|
| Hemostatics | 1 | 2018 | 11 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 27 | 0.150 |
Why?
|
| Hemostasis, Surgical | 1 | 2018 | 13 | 0.150 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 44 | 0.150 |
Why?
|
| Temperature | 2 | 2012 | 51 | 0.140 |
Why?
|
| Staining and Labeling | 1 | 2018 | 57 | 0.140 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 54 | 0.140 |
Why?
|
| Drug Discovery | 1 | 2018 | 36 | 0.140 |
Why?
|
| Protein Binding | 2 | 2016 | 200 | 0.140 |
Why?
|
| Equipment Design | 1 | 2018 | 179 | 0.140 |
Why?
|
| Second Messenger Systems | 1 | 2018 | 6 | 0.140 |
Why?
|
| Electrophysiology | 3 | 2007 | 72 | 0.140 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2017 | 3 | 0.140 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 78 | 0.140 |
Why?
|
| Molecular Imaging | 1 | 2018 | 20 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 113 | 0.130 |
Why?
|
| Nervous System | 2 | 2008 | 13 | 0.130 |
Why?
|
| Oncolytic Virotherapy | 1 | 2017 | 16 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 84 | 0.130 |
Why?
|
| Larva | 3 | 2008 | 4 | 0.130 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 15 | 0.130 |
Why?
|
| Sex Factors | 1 | 2018 | 676 | 0.130 |
Why?
|
| Neuropil | 1 | 2016 | 2 | 0.130 |
Why?
|
| Schizophrenia | 1 | 2016 | 32 | 0.130 |
Why?
|
| Cell Size | 1 | 2016 | 36 | 0.130 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2017 | 70 | 0.130 |
Why?
|
| Cofilin 1 | 1 | 2016 | 1 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2016 | 45 | 0.120 |
Why?
|
| Genes, Suppressor | 1 | 2016 | 2 | 0.120 |
Why?
|
| RNA Interference | 1 | 2016 | 77 | 0.120 |
Why?
|
| Mifepristone | 3 | 2008 | 4 | 0.120 |
Why?
|
| Genes, Switch | 2 | 2008 | 2 | 0.120 |
Why?
|
| Cues | 1 | 2016 | 67 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2017 | 138 | 0.120 |
Why?
|
| RNA | 1 | 2016 | 87 | 0.120 |
Why?
|
| Maze Learning | 2 | 2007 | 14 | 0.120 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2006 | 18 | 0.120 |
Why?
|
| Cytokines | 1 | 2017 | 247 | 0.120 |
Why?
|
| Sense Organs | 2 | 2005 | 2 | 0.120 |
Why?
|
| GABA Agonists | 1 | 2015 | 2 | 0.120 |
Why?
|
| Isoxazoles | 1 | 2015 | 4 | 0.120 |
Why?
|
| Arousal | 1 | 2015 | 19 | 0.120 |
Why?
|
| Urinary Bladder | 1 | 2017 | 183 | 0.120 |
Why?
|
| Olfactory Bulb | 2 | 2005 | 4 | 0.110 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 727 | 0.110 |
Why?
|
| Rats | 1 | 2018 | 1606 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2014 | 38 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2014 | 22 | 0.110 |
Why?
|
| Status Epilepticus | 1 | 2013 | 18 | 0.100 |
Why?
|
| Aged | 6 | 2018 | 10544 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2013 | 59 | 0.100 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 73 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 1066 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2018 | 3441 | 0.100 |
Why?
|
| Genetic Vectors | 2 | 2004 | 120 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 193 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 36 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 835 | 0.100 |
Why?
|
| Interferon-beta | 1 | 2012 | 18 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2012 | 3 | 0.090 |
Why?
|
| Cystectomy | 1 | 2013 | 106 | 0.090 |
Why?
|
| TRPC Cation Channels | 1 | 2012 | 2 | 0.090 |
Why?
|
| Biophysics | 1 | 2012 | 11 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 599 | 0.090 |
Why?
|
| Cadherins | 1 | 2012 | 27 | 0.090 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2012 | 25 | 0.090 |
Why?
|
| Appetite | 1 | 2012 | 23 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1012 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 69 | 0.090 |
Why?
|
| Middle Aged | 5 | 2018 | 12133 | 0.090 |
Why?
|
| Receptors, Odorant | 2 | 2014 | 2 | 0.090 |
Why?
|
| Intracellular Calcium-Sensing Proteins | 1 | 2010 | 1 | 0.090 |
Why?
|
| CREB-Binding Protein | 1 | 2010 | 4 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2010 | 6 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2011 | 46 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 126 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 888 | 0.080 |
Why?
|
| Spine | 1 | 2010 | 44 | 0.080 |
Why?
|
| Posture | 1 | 2010 | 56 | 0.080 |
Why?
|
| Ureteral Calculi | 1 | 2009 | 7 | 0.080 |
Why?
|
| Hot Temperature | 2 | 2006 | 78 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2010 | 136 | 0.080 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2009 | 17 | 0.080 |
Why?
|
| Kidney Calculi | 1 | 2009 | 23 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2012 | 287 | 0.070 |
Why?
|
| Intracellular Membranes | 1 | 2008 | 9 | 0.070 |
Why?
|
| DNA Probes | 1 | 2008 | 19 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 91 | 0.070 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 6 | 0.070 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2008 | 13 | 0.070 |
Why?
|
| Locomotion | 1 | 2008 | 31 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 134 | 0.070 |
Why?
|
| Exons | 1 | 2008 | 52 | 0.070 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 14 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 199 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 35 | 0.070 |
Why?
|
| Prosencephalon | 1 | 2007 | 5 | 0.070 |
Why?
|
| Swimming | 1 | 2007 | 7 | 0.070 |
Why?
|
| Microscopy, Electron | 1 | 2007 | 30 | 0.070 |
Why?
|
| Motor Skills | 1 | 2007 | 15 | 0.070 |
Why?
|
| Muscles | 2 | 2008 | 63 | 0.070 |
Why?
|
| Diphosphonates | 1 | 2007 | 9 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2007 | 65 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2008 | 119 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2007 | 19 | 0.070 |
Why?
|
| Bone Density Conservation Agents | 1 | 2007 | 23 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2007 | 39 | 0.060 |
Why?
|
| Imidazoles | 1 | 2007 | 92 | 0.060 |
Why?
|
| Cycloheximide | 1 | 2006 | 8 | 0.060 |
Why?
|
| Arrestins | 1 | 2006 | 3 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2006 | 11 | 0.060 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 99 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2010 | 349 | 0.060 |
Why?
|
| Exploratory Behavior | 1 | 2006 | 30 | 0.060 |
Why?
|
| Adult | 4 | 2018 | 9569 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2010 | 908 | 0.060 |
Why?
|
| Arrestin | 1 | 2005 | 1 | 0.060 |
Why?
|
| Genotype | 2 | 2006 | 731 | 0.060 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2005 | 1 | 0.060 |
Why?
|
| Fixatives | 1 | 2005 | 3 | 0.060 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2005 | 2 | 0.060 |
Why?
|
| Formaldehyde | 1 | 2005 | 11 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2005 | 7 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2005 | 43 | 0.060 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2005 | 12 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 55 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 90 | 0.060 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 8 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2005 | 48 | 0.060 |
Why?
|
| Ion Channel Gating | 1 | 2005 | 20 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 105 | 0.060 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2005 | 49 | 0.060 |
Why?
|
| Lasers | 1 | 2005 | 24 | 0.060 |
Why?
|
| TRPV Cation Channels | 1 | 2005 | 23 | 0.060 |
Why?
|
| Peptides | 1 | 2005 | 125 | 0.060 |
Why?
|
| Life Style | 1 | 2007 | 407 | 0.060 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2004 | 1 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 59 | 0.050 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2004 | 2 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2005 | 186 | 0.050 |
Why?
|
| 5' Flanking Region | 1 | 2004 | 1 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 24 | 0.050 |
Why?
|
| Receptors, Biogenic Amine | 1 | 2003 | 1 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 41 | 0.050 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2003 | 3 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2003 | 8 | 0.050 |
Why?
|
| Ovulation | 1 | 2003 | 7 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2003 | 29 | 0.050 |
Why?
|
| Differential Threshold | 1 | 2003 | 1 | 0.050 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2003 | 2 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2004 | 89 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2003 | 36 | 0.050 |
Why?
|
| Heterozygote | 1 | 2003 | 61 | 0.050 |
Why?
|
| Fear | 1 | 2003 | 50 | 0.050 |
Why?
|
| Purkinje Cells | 1 | 2003 | 2 | 0.050 |
Why?
|
| Cerebellar Cortex | 1 | 2003 | 4 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 14 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 255 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 69 | 0.050 |
Why?
|
| Potassium | 1 | 2003 | 40 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 50 | 0.050 |
Why?
|
| Ricin | 1 | 2002 | 4 | 0.050 |
Why?
|
| Acetylcholine | 1 | 2003 | 48 | 0.050 |
Why?
|
| DNA Transposable Elements | 1 | 2002 | 13 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 476 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 89 | 0.050 |
Why?
|
| Infant | 2 | 2013 | 1083 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2013 | 1282 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 195 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2734 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 1545 | 0.030 |
Why?
|
| Administration, Intravesical | 1 | 2017 | 23 | 0.030 |
Why?
|
| Oncolytic Viruses | 1 | 2017 | 8 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2017 | 68 | 0.030 |
Why?
|
| Child | 2 | 2013 | 2478 | 0.030 |
Why?
|
| Malus | 1 | 2014 | 9 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 1572 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 497 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2013 | 34 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2014 | 179 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 2329 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 31 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2012 | 3 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 103 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 362 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 152 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 433 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 764 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 894 | 0.020 |
Why?
|
| Genes, Mitochondrial | 1 | 2010 | 2 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2010 | 4 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2010 | 40 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 4034 | 0.020 |
Why?
|
| Software | 1 | 2010 | 124 | 0.020 |
Why?
|
| Glue Proteins, Drosophila | 1 | 2009 | 1 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 11 | 0.020 |
Why?
|
| North Carolina | 1 | 2013 | 1546 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 315 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2285 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2008 | 15 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 779 | 0.020 |
Why?
|
| Neuroglia | 1 | 2008 | 29 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2008 | 40 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 2008 | 55 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 2008 | 66 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 37 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2006 | 83 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2005 | 30 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 58 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 3705 | 0.010 |
Why?
|
| Octopamine | 1 | 2003 | 1 | 0.010 |
Why?
|
| Infertility, Female | 1 | 2003 | 6 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2003 | 39 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 58 | 0.010 |
Why?
|
| Ovary | 1 | 2003 | 58 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2003 | 2 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2003 | 2 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2003 | 2 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 172 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 468 | 0.010 |
Why?
|
| Stem Cells | 1 | 2003 | 314 | 0.010 |
Why?
|